← Back
$LRMR All transactions

Larimar Therapeutics, Inc.

A

$ Value

$0

Shares

153,822

Price

$0

Filed

Jan 27

Insider

Name

Clayton Russell

Title

Chief Medical Officer

CIK

0001530072

Roles

Officer

Transaction Details

Transaction Date

2026-01-26

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

153,822

Footnotes

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. | The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Filing Info

Accession No.

0001193125-26-024832

Form Type

4

Issuer CIK

0001374690

Clayton Russell's History

Date Ticker Type Value
2026-01-26 LRMR A $0
2026-01-26 LRMR A $0

Other Insiders at LRMR (90d)

Insider Bought Sold Last
Celano Michael
Chief Financial Officer
2026-01-26
BEN-MAIMON CAROLE
President and CEO
2026-01-26
Clayton Russell
Chief Medical Officer
2026-01-26
Shankar Gopi
Chief Development Officer
2026-01-26